GlassScriptPhysician profile
Hyland E Cronin
NPI 1356500011
$5,492.50
in general payments reported to CMS, 2019-2025
41 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,127 · 2020: $615 · 2021: $587 · 2022: $739 · 2023: $918 · 2024: $982 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,424.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $582.64 | 2019-2024 | Aklief, Oracea, Twyneo |
| Abbvie INC. | $578.42 | 2021-2025 | Rinvoq, Skyrizi |
| Revance Therapeutics, INC. | $360.79 | 2024-2025 | Daxxify |
| Amgen INC. | $313.19 | 2022-2025 | Otezla, Enbrel, Otezla |
| Genzyme Corporation | $305.37 | 2020-2024 | |
| Encore Dermatology INC. | $287.41 | 2019-2020 | |
| Journey Medical Corporation | $276.82 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $255.15 | 2019-2025 | Libtayo, Dupixent |
| Sun Pharmaceutical Industries INC. | $218.56 | 2021-2025 | Absorica Ld, Winlevi, Ilumya |
| Almirall LLC | $209.93 | 2019-2022 | |
| Pfizer INC. | $195.26 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $181.21 | 2019-2024 | |
| Kerecis Limited | $180.17 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $179.50 | 2021-2023 | Puraply |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $145.09 | 2019-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyland Cronin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.